Advanced Search:

BAX - Baxter International

$40.33  -1.79 (-4.25%)

Updated: 03:15 May 5, 2024 EST

Next Hour's AI Forecast

98.13%

Avg. Accuracy (AI)

$36.77

Next Session's AI Forecast

96.24%

Avg. Accuracy (AI)

$41.13

Next Week's AI Forecast

100%

Trend's Accuracy (AI)

$40.86

Baxter International's Position Within the Medical Instruments & Supplies Industry
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)

BAXTER INTERNATIONAL - HISTORICAL DATA 6M

  • Last price

    $ 40.33

  • Daily change

    $ -1.79

  • Previous Close

    $ 42.12

  • Last Updated

    03:15 May 5, 2024 EST

CURRENT VOLATILITY

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
-3.46 -0.76 -0.16 0.07 -0.08

CURRENT VOLATILITY RANK

Variation from the lowest to the highest value in a period.

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
3.46 1.47 1.21 1.17 1.22

STOCHASTIC METRIC

The STOCHASTIC METRIC shows when a financial asset has moved into an overbought or oversold position.

OVERSOLD
OVERBOUGHT
Curr. Week Next Week Curr. Month Curr. Quarter
0% 0% 0% 0%

MOVING AVERAGE METRIC

5 Sessions Change 5 Sessions 20 Sessions Change 20 Sessions 50 Sessions Change 50 Sessions 200 Sessions
36.32 -7.42% 39.23 -3.9% 40.82 4.94% 38.9

RSI METRIC

RS Hour RSI Hour RS Day RSI Day
0.71 71.99 0.4 41.52

Baxter International Technical Analysis News

Baxter International

One Baxter Parkway
Deerfield, IL 60015
United States
224 948 2000
https://www.baxter.com

Sectors: Healthcare
Industry: Medical Instruments & Supplies
F. Time Employees: 60000
Description

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Corporate Governance

Baxter International Inc.’s ISS Governance QualityScore as of May 1, 2024 is 4. The pillar scores are Audit: 5; Board: 5; Shareholder Rights: 1; Compensation: 8.

BAXTER INTERNATIONAL'S HOLDERS RANK

List of holders with stock participation in Baxter International.